Scipher
Holding Companies & Conglomerates · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Dawley Rd, London, Greater London, UB3 1...Phone Number
+44 2088486555Website
www.scipher.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Scipher
Scipher is currently under construction and has not yet released information about its products or services. The company is expected to provide updates in the near future. Details regarding intended clients are also not available at this time.Explore more
Popular SearchesScipher PLCScipherScipher MedicineScipher Medicine CorpSIC Code 67,671NAICS Code 55,551Show moreScipher Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scipher your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Scipher has new funding data
Scipher, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Scipher
Website visits: Recent activity has been detected on your website
Check if Scipher has recently received funding, and reach out quickly before it becomes old news!
Check out if Scipher is spiking on competitors!
Product Launch: Get notified when Scipher launches new products
Click to see if Scipher had a recent Job posting/layoffs
Earning: See what the market has to say on Scipher recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Scipher is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
Scipher is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Scipher.
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Event
Events
Event
Events
Scipher News & Media
Scipher Medicine Unveils New Tool to Predict Rheumatoid Arthritis Treatment Success at EULAR 2025
WALTHAM, Mass.--(BUSINESS WIRE)--At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind the groundbreaking PrismRA® test, unveiled a new, AI-driven approach to help doctors better evaluate if a rheumatoid arthritis (RA) treatment is truly working — a challenge that has long frustrated both patients and physicians. This new “RA Response Calculator,” developed using real-world patient data and machine learning, offers a more accurate way to determine whether sScipher Medicine expands its global presence, bringing precision medicine to Latin America through an alliance with Grupo Amarey
WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leading precision immunology company, today announced a strategic alliance with Grupo Amarey, a leading company in the representation and distribution of technologies, solutions, and services for the healthcare sector in Colombia, Panama, and Costa Rica, to expand the global reach of its innovative precision diagnostic, PrismRA®. This collaboration marks Scipher Medicine’s first international expansion, bringing personalized medicine solutionScipher Medicine Announces Collaboration with Top-Three Pharmaceutical Company to Integrate Precision Medicine into Clinical Trial Design
WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a precision immunology company dedicated to transforming patient care through data-driven insights, today announced a strategic collaboration with a top 3 global pharmaceutical company. The partnership aims to enhance clinical trials by incorporating PrismRA®, Scipher's proprietary precision medicine diagnostic, into an ongoing trial. PrismRA is designed to analyze a patient’s molecular profile to predict non-response to certain therapies, enabScipher Medicine and Kythera Labs Partner to Unlock New Insights into Autoimmune Disease-Specific Treatment
WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Kythera Labs, a leading healthcare data and technology company, announced a partnership to advance rheumatology treatment discovery. The integration of Scipher’s real-world clinical and genomic data (biobank) insights with Kythera’s enriched high-fidelity multi-source data assets will empower Scipher to further leverage this unique data derived from PrismRA® for precision medicine diag
Read more news
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scipher
Sign Up For FreeTo access detailed company insights
Scipher is currently under construction and has not yet released information about its products or services. The company is expected to provide updates in the near future. Details regarding intended clients are also not available at this time.... Read More
